EUVIMEDEUVIMED entdecken
EditorialOpen Access

A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy

Uttam K Sinha, De-Chen Lin

Theranostics · 2023

DOI: 10.7150/thno.83486 ↗

Kurz gefasst

Editorial in der Zeitschrift Theranostics, 2023. Verfasst von Uttam K Sinha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA. Hauptthemen laut MEDLINE: Transcription Factors, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsNeoplasmsHumansSignal TransductionGene Expression RegulationImmunotherapyTumor Microenvironment

Substanzen

Transcription Factors

Autor:innen und Institutionen

  • Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Sinha, U. K., & Lin, D. C. (2023). A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy. Theranostics. https://doi.org/10.7150/thno.83486

Vancouver

Sinha UK, Lin DC. A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy. Theranostics. 2023. doi:10.7150/thno.83486

BibTeX
@article{Sinha2023,
  author = {Sinha, Uttam K and Lin, De-Chen},
  title = {A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.83486}
}
Kostenlos starten →